FDA Inspection 1275189 — Xinyu Pharmaceutical Co., Ltd.

Xinyu Pharmaceutical Co., Ltd. — FEI 3006895831

The FDA completed an inspection of Xinyu Pharmaceutical Co., Ltd. on Jun 27, 2025 in Suzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 27, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Suzhou (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.